NovaBay Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-2.73
Price/Sales ratio
2.30
Earnings per Share (EPS)
$-0.35

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
N/AN/AN/A-7.96-1.67-1.21-2.21-2.22-0.12-0.08-0.07-1.67
Price/Sales ratio
N/AN/AN/A3.230.871.932.461.730.140.050.041.93
Price/Book Value ratio
N/AN/AN/A22.742.2113.101.981.430.190.250.0913.10
Price/Cash Flow ratio
N/AN/AN/A-9.40-1.97-1.60-5.17-1.58-0.30-0.20-0.09-1.97
Price/Free Cash Flow ratio
N/AN/AN/A-9.05-1.95-1.60-5.15-1.57-0.30-0.20-0.09-1.95
Price/Earnings Growth ratio
N/AN/AN/AN/A0.08-0.040.060.04-0.000.000.00-0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
53.88%71.21%79.28%84.72%87.98%73.66%60.03%67.03%54.01%53.61%54.02%73.66%
Operating Profit Margin
-1601.32%-479.66%-92.30%-40.10%-62.92%-142.44%-64.68%-105.23%-53.31%-33.97%-94.38%-94.38%
Pretax Profit Margin
-1441.36%-433.02%-110.52%-40.59%-52.29%-146.26%-111.07%-69.16%-73.64%-65.46%-64.11%-64.11%
Net Profit Margin
-1441.55%-433.07%-110.54%-40.60%-52.32%-158.91%-111.12%-77.88%-112.92%-65.46%-64.11%-64.11%
Effective Tax Rate
-0.01%-0.06%-0.01%-0.04%-0.06%-0.06%-0.04%79.24%35.90%N/AN/A-0.06%
Return on Assets
-201.59%-373.70%-85.50%-73.44%-69.91%-93.46%-72.44%-27.35%-99.18%-106.70%-78.50%-93.46%
Return On Equity
-822.18%372.16%-185.19%-285.38%-132.11%-1077.80%-89.61%-64.48%-154.11%-290.88%-89.04%-132.11%
Return on Capital Employed
-402.62%-4732.88%-99.31%-143.35%-142.74%-169.88%-51.80%-43.15%-63.25%-105.19%-156.07%-169.88%
Liquidity Ratios
Current Ratio
2.070.973.341.802.231.645.02N/AN/AN/A2.662.23
Quick Ratio
1.920.683.141.702.161.564.812.891.850.991.721.56
Cash ratio
1.620.512.200.640.821.214.212.181.250.731.250.82
Days of Sales Outstanding
94.5344.6565.0474.38101.9358.9640.6372.2949.9918.8135.8658.96
Days of Inventory outstanding
391.28389.31129.3266.0767.99103.3255.89423.37189.41153.72135.9067.99
Operating Cycle
485.82433.97194.36140.45169.92162.2896.53495.67239.41172.53144.74162.28
Days of Payables Outstanding
1.40K718.7167.4061.09133.8069.5127.76137.4059.5160.3742.7069.51
Cash Conversion Cycle
-914.84-284.74126.9679.3636.1192.7768.77358.27179.89112.1526.6792.77
Debt Ratios
Debt Ratio
N/A0.32N/AN/AN/A0.310.020.010.020.180.350.35
Debt Equity Ratio
N/A-0.32N/AN/AN/A3.630.030.020.040.490.553.63
Long-term Debt to Capitalization
N/A-0.48N/AN/AN/AN/AN/AN/AN/AN/A0.13N/A
Total Debt to Capitalization
N/A-0.48N/AN/AN/A0.780.030.020.040.320.160.78
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A-11.21N/AN/AN/A-2.23-11.34-30.13-14.68-2.53-5.10-2.23
Company Equity Multiplier
4.07-0.992.163.881.8811.531.232.351.552.721.5511.53
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-14.28-4.23-1.02-0.34-0.44-1.20-0.47-1.09-0.46-0.28-0.51-0.51
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.011.031.001.001.001.001.011.001.011.00
Cash Flow Coverage Ratio
N/A-11.21N/AN/AN/A-2.23-11.34-30.13-14.68-2.53-5.10-2.23
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-2.23-11.34-30.13-14.68-2.53-22.98-2.23
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A